Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Adults with longevity and biological aging optimization goals who want a foundational anti-aging intervention alongside other longevity peptides and lifestyle protocols Patients with age-related sleep deterioration and circadian rhythm disruption who have not responded adequately to standard sleep interventions Patients with documented age-related decline in multiple biological markers (antioxidant capacity, immune function, hormonal balance) for whom a broad-spectrum bioregulator approach is appropriate Patients already engaged in comprehensive longevity protocols (NMN, GH secretagogues, NAD+ optimization) who want to add a pineal-axis and telomere-focused component Patients over 45 to 50 where age-related biological decline provides the clinical rationale for a geroprotective intervention The cancer contraindication for Epitalon requires specific attention in the clinical assessment
For most people, the overall cancer risk remains very low
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with comorbidities
In contrast, peptides improve protein synthesis and tissue repair
IGF-1 DES exhibits moderate side effects, low oral and excellent subcutaneous bioavailability in mice
